Jan Martin Berke

1.5k citations

31 papers · 1.0k indexed · h-index 16

Hepatology top 1%
- Hepatitis C virus research 26
Epidemiology top 5%
- Hepatitis B Virus Studies 18
- Liver Disease Diagnosis and Treatment 6
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 6
- Viral Infections and Outbreaks Research 4
Virology top 10%
Ecology
- Bacteriophages and microbial interactions 4
Molecular Biology
- Biochemical and Molecular Research 6
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5

Co-authors: Pascale Dehertogh Karen Vergauwen Koen Vandyck Frederik Pauwels Darius Moradpour Oliver Lenz Pierre Raboisson Wendy Mostmans
Cited by: Hepatology Epidemiology Infectious Diseases
Journals: Antimicrobial Agents and Chemotherapy (6 papers)Journal of Hepatology (3 papers)Journal of Medicinal Chemistry (3 papers)
Partner nations: Belgium United States Switzerland

In The Last Decade

Jan Martin Berke

30 papers receiving 991 citations

Peers

Countries citing papers authored by Jan Martin Berke

Since Specialization

Citations

This map shows the geographic impact of Jan Martin Berke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Martin Berke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Martin Berke more than expected).

Fields of papers citing papers by Jan Martin Berke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Martin Berke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Martin Berke. The network helps show where Jan Martin Berke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan Martin Berke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Martin Berke Line = papers co-authored together Jan Martin Berke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation Journal of Virology ·Jan Martin Berke,小林泰賀,Katharina Siedler,Daitze Wu,Ke Zhang,Nádia Conceição‐Neto,孝広小林,Desheng Kong,George Kukolj,Chris Li,Zhengdong Ren,Isabel Nájera,Frederik Pauwels	2024	4
2	Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR Nature Communications ·Lauriane Lecoq,Obana P. Osain,薛益明,Marie‐Laure Fogeron,Shishan Wang,Cornelia Stöckl,勝代喜納,Thomas Wiegand,Morgane Callon,Alexander A. Malär,David Durantel,Dara Burdette,Jan Martin Berke,Beat H. Meier,Michael Nassal,Anja Böckmann	2023	11
3	Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures Journal of Virological Methods ·Katharina Siedler,Karen Vergauwen,Steffen Jaensch,Emmanuel Gustin,Christoph Rüttimann,Peter Vermeulen,Aaron Lin,Koen Vandyck,Frederik Pauwels,Jan Martin Berke	2021	6
4	Virology analysis of chronic hepatitis B virus–infected patients treated for 28 days with JNJ‐56136379 monotherapy Journal of Viral Hepatitis ·Thierry Verbinnen,Echuri,Willem Talloen,Jan Martin Berke,David R. Blue,Jeysen Yogaratnam,Joris Vandenbossche,Umesh Shukla,Sandra De Meyer,Oliver Lenz	2020	14
5	Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation Frontiers in Molecular Biosciences ·Shishan Wang,Marie‐Laure Fogeron,Anderson Wac,Cornelia Stöckl,Susanne Penzel,Dara Burdette,Jan Martin Berke,Michael Nassal,Lauriane Lecoq,Beat H. Meier,Anja Böckmann	2019	20
6	Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects Advances in Therapy ·Joris Vandenbossche,Wolfgang Jessner,Liang Ban,Jeike Biewenga,Jan Martin Berke,Willem Talloen,Loeckie De Zwart,Jan Snoeys,Jeysen Yogaratnam	2019	23
7	Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library Antiviral Research ·滋成長谷川,Peggy Geluykens,خـاسف جمال الدين,清策森田,Olivia Goethals,Bilinç Doğruöz Karatekin,T. Prazuck,Stefaan Last,David C. McGowan,Thomas Koellner,Benoît De Boeck,Bart Stoops,Benoit Devogelaere,Frederik Pauwels,Koen Vandyck,Jan Martin Berke,Pierre Raboisson,Kenneth Simmen,Péter Hajnal,Marnix Van Loock	2017	15
8	Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro Antiviral Research ·Jan Martin Berke,小林泰賀,Thierry Verbinnen,Pascale Dehertogh,Karen Vergauwen,Ann Vos,Oliver Lenz,Frederik Pauwels	2017	25
9	Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Pascale Dehertogh,Karen Vergauwen,Ellen Van Damme,Wendy Mostmans,Koen Vandyck,Frederik Pauwels	2017	116
10	Discovery of 1-((2R,4aR,6R,7R,7aR)-2-Isopropoxy-2-oxidodihydro-4H,6H-spiro[furo[3,2-d][1,3,2]dioxaphosphinine-7,2′-oxetan]-6-yl)pyrimidine-2,4(1H,3H)-dione (JNJ-54257099), a 3′-5′-Cyclic Phosphate Ester Prodrug of 2′-Deoxy-2′-Spirooxetane Uridine Triphosphate Useful for HCV Inhibition Journal of Medicinal Chemistry ·Tim H. M. Jonckers,Abdellah Tahri,Leen Vijgen,Jan Martin Berke,Sophie Lachau‐Durand,Bart Stoops,Jan Snoeys,Laurent Leclercq,Lotke Tambuyzer,Tse‐I Lin,Kenny Simmen,Pierre Raboisson	2016	18
11	A Cellular Replicon-Based Phenotyping Assay to Determine Susceptibility of Hepatitis C Virus Clinical Isolates to NS3/4A Protease Inhibitors Methods in molecular biology ·Leen Vijgen,Jannick Verbeeck,Marin Nikolac,Jan Martin Berke,Diana Koletzki,Gregory Fanning,Oliver Lenz	2013	5
12	Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202) Journal of Hepatology ·Oliver Lenz,Leen Vijgen,Jan Martin Berke,Maxwell D. Cummings,Bart Fevery,Monika Peeters,Goedele De Smedt,Christophe Moreno,Gastón Picchio	2012	69
13	MAPPIT as a High-Throughput Screening Assay for Modulators of Protein–Protein Interactions in HIV and HCV Methods in molecular biology ·和弘上松,V.V. Shapoval,和畅,Dirk Jochmans,R. Clayton,Jan Martin Berke,Sam Lievens,José Van der Heyden,Jan Tavernier	2011	6
14	Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase Antimicrobial Agents and Chemotherapy ·Jan Martin Berke,Leen Vijgen,Sophie Lachau‐Durand,Megan H. Powdrill,Andreia Domingues Pereira,Suvrath Mahadevan,Staffan Eriksson,Matthias Götte,Els Fransen,Pascale Dehertogh,Christel Van den Eynde,Laurent Leclercq,Tim H. M. Jonckers,Pierre Raboisson,Magnus Nilsson,Bertil Samuelsson,Åsa Rosenquist,Gregory Fanning,Tse‐I Lin	2011	6
15	Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex Journal of Virological Methods ·Jan Martin Berke,Denis Fenistein,Frederik Pauwels,León E. Graneros,Oliver Lenz,Tse‐I Lin,Eberhard Krausz,Gregory Fanning	2010	8
16	Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex Proceedings of the National Academy of Sciences ·Volker Brass,Jan Martin Berke,Roland Montserret,Hubert E. Blum,François Pénin,Darius Moradpour	2008	100
17	Hepatitis C virus comes full circle Hepatology ·Jan Martin Berke,Darius Moradpour	2005	5
18	Characterization of Nonstructural Protein Membrane Anchor Deletion Mutants Expressed in the Context of the Hepatitis C Virus Polyprotein Journal of Virology ·Rainer Gosert,Xun Le-Min,Jan Martin Berke,Volker Brass,Hubert E. Blum,Darius Moradpour	2005	9
19	Upregulation of Protein Phosphatase 2Ac by Hepatitis C Virus Modulates NS3 Helicase Activity through Inhibition of Protein Arginine Methyltransferase 1 Journal of Virology ·François H.T. Duong,Verena Christen,Jan Martin Berke,Marco Piragnolo,Darius Moradpour,Markus H. Heim	2005	77
20	Synthesis and spectroscopic investigations of the formamidino complexes [M(π-C5H5) {HC(N-p-tolyl)2} (CO)L] (M = Mo, W; L = PPh3, AsPh3, SbPh3, P(OPh)3, P(OMe)3) and [Mo(π-C5H5) {HC(N-p-tolyl)2} (NO)X] (X = Cl, Br, I) Journal of Organometallic Chemistry ·Любовь Валерьевна Захарова,Jan Martin Berke,A. Oskam,Kees Vrieze	1978	13

About Jan Martin Berke

Jan Martin Berke is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (18 papers), Liver Disease Diagnosis and Treatment (6 papers), Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Bacteriophages and microbial interactions (4 papers) and Viral Infections and Outbreaks Research (4 papers). The work is most often cited by research in Hepatology (764 citations), Epidemiology (712 citations) and Infectious Diseases (340 citations). Jan Martin Berke has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Pascale Dehertogh, Karen Vergauwen, Koen Vandyck, Frederik Pauwels, Darius Moradpour, Oliver Lenz, Pierre Raboisson, Wendy Mostmans, Leen Vijgen and Maxwell D. Cummings. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology, Journal of Medicinal Chemistry, Journal of Virology and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact